Primary central nervous system plasmablastic lymphoma presenting in human immunodeficiency virus-negative but Epstein-Barr virus-positive patient: A case report
© Zhang et al.; licensee BioMed Central Ltd. 2012
Received: 17 March 2012
Accepted: 30 April 2012
Published: 8 May 2012
We report a 32-year-old Outer Mongolian man, with plasmablastic lymphoma (PBL) primarily occured in the central nervous system and diagnosed by surgical resection. This patient appeared headache and Magnetic resonance imaging (MRI) showed multiple lesions in the right cerebral hemisphere including the right frontal-parietal lobe and right basal ganglia and the left cerebellum, he was diagnosed as lymphoma by stereotactic biopsy in January 2009 in local hospital, and was given radiotherapy 33 times after the biopsy. The patient was admitted to The Military General Hospital of Beijing PLA., Beijing, P.R. China on March 9th, 2011, with chief complaints of right limbs convulsioned suddenly, then fell down and lose of his consciousness, then awoke after 4 to 5 minutes, with symptoms of angulus oris numbness and the right upper limb powerless ten days ago.
MRI of the brain revealed a well-defined hyperdense and enhancing mass in the left frontal-parietal lobe, the meninges are closely related, there was extensive peritumoural edema noted with pressure effects, as evident by effacement of the left lateral ventricles and a 0.5 cm shift of the midline to the right side.
Surgical resection showed markedly atypical, large singly dispersed or cohesive proliferation of plasmacytoid cells with frequent abnormal mitoses and binucleation, some neoplastic cells were large with round or oval nuclei and showed coarse chromatin and smaller or unapparent nucleoli, some neoplastic cells with prominent nucleoli, apoptosis and necrosis were often presented. Immunohistochemistry staining and gene rearrangement together with other supportive investigation confirmed the diagnosis of primary central nervous system plasmablastic lymphoma. A month later, he was started on chemotherapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, leurocristime and prednisone) for a week. Other supportive treatment was provided for symptomatic epilepsy. The patient regained muscle strength in both upper limbs and right lower limb and the symptomatic epilepsy was controlled after two weeks. Then the patient was discharged. Follow-up data shows the patient to be alive eleven months after discharge.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1649317674697046.
KeywordsPlasmablastic lymphoma Central nervous system Human immunodeficiency virus Epstein-barr virus
Unlike the numerous subtypes of extra-central nervous system (CNS) lymphoma, most primary central nervous system lymphomas (PCNSLs) are a high-grade non-Hodgkin’s subtype with the features of diffuse large B cell lymphoma (DLBCL). So far there were two cases of primary central neurous system PBL reports in the world. One case occurred in the right basal ganglian , another occurred in the left anterior frontal lobe and both patients were HIV-positive. Here we report a HIV-negative but EBV-positive patient with a primary CNS plasmablastic lymphoma, a rare variant of DLBCL.
A 32-year-old Outer Mongolian man, who is a freelancer, was born and grew up in the city of Ulan Bator, Capital of Outer Mongolia. Ten days ago his right limbs convulsioned suddenly, then he fell down and lose of consciousness, and awoke after 4 to 5 minutes, with symptoms of angulus oris numbness and the right upper limb powerless. He was referred to The Military General Hospital of Beijing PLA., Beijing, P.R. China on March 9th, 2011.
The patient accepted a eye operation because of acute glaucoma in 2008, he denied any infection and family histories such as HIV, HBV, HCV, HPV, Syphilis infections, cancer or hereditary diseases or organ transplantation history. He never knew the infection of EBV before this admission. He had no bad habits such as smoking and alcoholism, no dust, toxins, radioactive material exposure history, had never been to infectious disease areas, had no habit of eating raw fish and raw meat, etc.
On admission, the patient was with no fever, papilloedema, but some neurological deficits including the myodynamia of the proximal end of right upper limb was stage IV, distal end of the right upper limb was stage III, the myodynamia of the right lower limb was stage IV, and Babinski syndrome (+), etc. noted on physical examination. Physical inspection revealed no enlargement of general superficial lymph nodes and no mass was found in the head and neck region, including the oral cavity.
Blood inspection showed that WBC 7.63x109/L, neutrophils 80.9%, RBC 4.6x1012/L, hemoglobin 139.0 g/L, PLT 234x109/L; Biochemical inspection showed that ALT 17 U/L, TBIL 9.60umol/L, DBIL 4.1 umol/L, TP 60.3 g/L, ALB 46.2 g/L, GLU 6.4 mmol/L, BUN 5.90 mmol/L, Cr 67.0 umol/L, all these indexes were within the normal range. He was detected with no HIV, HBsAg, HBcAg, HPV, Syphilis infection after this admission.
Details of the results of immunohistochemistry staining in tumor cells
Diffusely cell membrane positive
Diffusely cell membrane positive
Diffusely cell membrane positive
Partly nuclei positive
Kappa light chain
Partly cytoplasm positive
Lambda light chain
Partly cytoplasm positive
Partly cell membrane positive
Plasma cell marker
Partly cytoplasm positive
Nuclei positive index was about 75%
Follow up data by regular visits to this patient, after the operation, the patient was given anti-epileptic therapy, and started on chemotherapy with R-CHOP (rituximab, cyclophosphamide, doxorubicin, leurocristime and prednisone) for one week. Two weeks later, the symptoms of right limbs twitching were well controled, hemiplegy of right limbs mainly disappeared. Then the patient was discharged. Follow-up data shows the patient to be alive eleven months after discharge.
Plasmablastic lymphoma (PBL) is a rare, highly invasive lymphoma, with diffuse proliferation of large neoplastic cells most of which resemble B immunoblasts, some tumor cells have immunophenotype of plasma cells. It was a unique subtype of diffuse large B cell lymphoma. It usually occures in HIV-positive individuals, predominantly males. In recent years more researches show that the pathogenesis of PBL has relationship with EBV and HHV8 [3–5]. Tereza CC et al. revealed that the frontal cortex is the main region to be frequently observed neurological lesions after being infected by Bovine Herpesvirus type 5 (BoHV-5) comparing with parietal cortex, thalamus and mesencephalon . To the best of our knowledge, this is the first case report for PBL occurence in the intracranial frontal and parietal cortex region with HIV negative but EBV positive, demonstrating the occurance of this disease had relationship with the infection of EBV.
In this case immunophenotype showed that the neoplastic cells express a plasma cell phenotype including CD38, positive for LCA, CD79a and Mum-1, high Ki67 proliferation index, extronodal localization, and the presence of EBV by in situ hybridization for EBER all supported the diagnosis of plasmablastic lymphoma.
In PBL clonal IgH chain and MYC gene rearrangement is demonstrable, especially in those EBV-positive patients, may show evidence of somatic hypermutation or be in an unmutated configuration . In this case the plasmacytoid neoplastic cells occurred IgH gene rearrangement, both kappa and lambda light chains by immunohistochemistry staining and gene rearrangement using polymerase chain reaction method, it illustrated that this case was a neoplastic lesions.
PBL should be morphologically distinguished with anaplastic or plasmablastic plasma cell myeloma, immunoblastic cell type diffuse large B-cell lymphoma, anaplastic diffuse large B-cell lymphoma, ALK-positive large B-cell lymphoma, primary effusion lymphoma and HHV8-related origin of Castleman's disease, multi-center B-cell lymphoma, and so on. It is easy to make the correct diagnosis according to clinical history (immune deficiency), disease site, tumor cell phenotype, high proliferation index and EBER in situ hybridization, etc. Owing to the PBL in this case occurred in the skull, it is also need to be clinically and pathologically distinguished with some other diseases such as central nervous system metastases tumors, germ cell tumors, malignant melanoma, glioblastoma multiform and so on which also occurring in the brain. Central nervous system metastases usually oppear at the cerebrum and duramater places, especially the cinerea and white matter junction. CT scan showing a clear boundary, equal density or low density round lesions, with obvious peritumoral edema. MRI showed low signal on T1WI, high signal in T2WI, obvious peritumoral edema, with enhanced signals when enhancement. The metastases tumors in the brain are round or confluent, with clear border, gray or brown, and other organs within the body is generally able to find the primary tumor. The tumor cells can be distinguished with PBL by morphology and immunophenotype. Germ cell tumors are similar to PBL in morphology, which also have round or oval large cells and prominent nucleoli, with a background of small lymphocytes, but 90% of the central nervous system germ cell tumors involving patients under the age of 20, the peak age of 10–12 years old. It commonly occures in the pineal gland, the secondary place is saddle. The germ cell tumors immunophenotypes are different from PBL, the former can express PLAP and CD117, also express low molecular weight keratin, but do not express LCA, and plasma cells markers. The tumor cells of malignant melanoma in morphology could be alike with PBL, such as increased nucleus and nucleolus, with deeply stained and coarse chromatin, the mitosis and necrosis are easy to find. Immunohistochemistry staining showed malignant melanoma express S100, HMB-45 and Melan-A, but PBL don’t express these markers. Glioblastoma multiform is a rare glial tumors occur in children, adolescents and young people, commonly sites are frontal lobe and parietal lobe, the mass usually has clearly manifested boundaries Cell differentiation to obesity glioblastoma in morphology also can be similar to PBL, the nucleus looks like plasma cell-like, but can be found fence-like or polar arrangement tumor cells around the hyperplastic blood vessels and necrosis. The former express GFAP, S100 and other neurogenic protein and glial markers to make a confirm diagnosis.
About prognosis and predictive factors of PBL, the clinical course is very aggressive. Most patients are stage III or IV when they see a doctor. In addition, these disease is not sensitive to chemotherapeutics, and lack of standard chemotherapy regimen. Most of the patients dying in the first year after the diagnosis , primary central nervous system lymphomas (PCNSL) coexsited with HIV, the median srvival was 1.3 months .Those not primary central neurous system PBL but involved CNS, the median overall survival is about one month .
This case report also emphasizes the importance of clinical and radiological correlation in the diagnosis of this lethal disease.
Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Diffuse large B cell lymphoma Central
central nervous system
Primary central nervous system lymphomas
Magnetic resonance imaging.
Here we express our thanks to Professor Xiao Ge Zhou (Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China) for his assistant diaganosis of this PBL. There is no conflict or financial support.
- Urrego PA, Smethurst M, Fowkes M, Peterson B, Strauchen J, Wu M, Szporn AH, Chen H: Primary CNS plasmablastic lymphoma: report of a case with CSF cytology, flow cytometry, radiology, histological correlation, and review of the literature. Diagn Cytopathol. 2011, 39: 616-620. 10.1002/dc.21520.View ArticlePubMed
- Shuangshoti S, Assanasen T, Lerdlum S, Srikijvilaikul T, Intragumtornchai T, Thorner PS: Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol. 2008, 34: 245-247. 10.1111/j.1365-2990.2007.00904.x.View ArticlePubMed
- Christensen H, Boysen G: C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis. 2004, 18: 214-9. 10.1159/000079944.View ArticlePubMed
- Corti M, de Dios Soler M, Bare P, Villafane MF, De Tezanos Pinto M, Perez Bianco R, Narbaitz M: AIDS related lymphomas: Histopathological subtypes and association with Epstein Barr virus and Human Herpes virus type-8. Medicina (B Aires). 2010, 70: 151-158.
- Verma S, Nuovo GJ, Porcu P, Baiocchi RA, Crowson AN, Magro CM: Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol. 2005, 32: 35-39. 10.1111/j.0303-6987.2005.00258.x.View ArticlePubMed
- Cardoso TC, Ferrari HF, Garcia AF, Bregano LC, Andrade AL, Nogueira AH: Immunohistochemical approach to the pathogenesis of clinical cases of bovine Herpesvirus type 5 infections. Diagn Pathol. 2010, 5: 57-64. 10.1186/1746-1596-5-57.PubMed CentralView ArticlePubMed
- Valera A, Balague O, Colomo L, Martinez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E: IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010, 34: 1686-1694.PubMed CentralPubMed
- Riedel DJ, Gonzalez-Cuyar LF, Zhao XF, Redfield RR, Gilliam BL: Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis. 2008, 8: 261-267. 10.1016/S1473-3099(08)70067-7.View ArticlePubMed
- Raez LE, Patel P, Feun L, Restrepo A, Raub WA, Cassileth PA: Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Crit Rev Oncog. 1998, 9: 199-208.PubMed
- Ustun C, Reid-Nicholson M, Nayak-Kapoor A, Jones-Crawford J, McDonald K, Jillella AP, Ramalingam P: Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol. 2009, 88: 351-358. 10.1007/s00277-008-0601-x.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.